Skip to main content
SpringerLink
Log in

Alkaline Phosphatase: Does it have a Role in Predicting Hepatocellular Carcinoma Recurrence?

  • Original Article
  • Published:
Journal of Gastrointestinal Surgery Aims and scope

Abstract

Backgrounds

Surgical resection remains the first line of treatment for earlier stages of hepatocellular carcinoma (HCC), and it offers the best prognosis for long-term survival. Nevertheless, the recurrence rates after resection are still high in reports. Therefore, it is still essential to explore any potential prognostic factors to attain relatively longer-term survival of HCC patients.

Materials and Methods

In the period from 1983 to 2005, 1,685 patients who underwent hepatectomy at Chang Gung Memorial hospital were enrolled in the study, and their clinicopathological data were retrospectively reviewed for survival analysis.

Results

The 1-, 3-, 5-, and 10-year disease-free survival (DFS) rates in this series were 60.3%, 39.7%, 31.3%, and 24.0%, respectively, whereas the 1-, 3-, 5-, and 10-year overall survival (OS) rates were 80.1%, 59.1%, 46.6%, and 27.7%, respectively. Gross vascular invasion, tumor status, lymph node involvement, satellite lesion, positive surgical margin, alkaline phosphatase (ALP), albumin, presence of cirrhosis, and Child grade B or C were independent prognostic factors for prediction of DFS; while α-fetoprotein, ALP, surgical factors, including complications, blood transfusion, positive resection margin, and tumor characters including tumor status, vascular invasion, and lack of tumor encapsulation were found to be independent predicting factors for OS, as determined by Cox regression analysis. Interestingly, we found that preoperative level of ALP was one of the most important independent predictors of recurrence, even more important that α-fetoprotein (AFP) as we noticed that elevation of ALP above (82 U/L) predicted poor prognosis in patients where AFP levels was less than 66 ng/ml. It is worth to mention that ALP was statistically related to other liver function tests, but not tumor characters by hierarchical clustering; which means that we were able to correlate ALP with prognosis statistically, but not with pathological criteria of the tumor; to elucidate these finding, further basic science research is required.

Conclusion

ALP among liver function tests, in addition to other tumor characters were independent factors for DFS and OS; our results suggest that preoperative ALP levels could be utilized to monitor and predict recurrence in high risk HCC patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Bosch,F.X., J.Ribes, M.Diaz, and R.Cleries. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004;127:S5-S16.

    Article  PubMed  Google Scholar 

  2. Lu,S.N., W.W.Su, S.S.Yang, T.T.Chang, K.S.Cheng, J.C.Wu, H.H.Lin, S.S.Wu, C.M.Lee, C.S.Changchien, C.J.Chen, J.C.Sheu, D.S.Chen, and C.H.Chen. Secular trends and geographic variations of hepatitis B virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan. Int. J. Cancer 2006;119:1946–1952.

    Article  PubMed  CAS  Google Scholar 

  3. Poon,R.T., S.T.Fan, I.O.Ng, C.M.Lo, C.L.Liu, and J.Wong. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 2000;89:500–507.

    Article  PubMed  CAS  Google Scholar 

  4. Yanaga,K. Current status of hepatic resection for hepatocellular carcinoma. J. Gastroenterol. 2004;39:919–926.

    Article  PubMed  Google Scholar 

  5. Wu,J.C., Y.H.Huang, G.Y.Chau, C.W.Su, C.R.Lai, P.C.Lee, T.I.Huo, I.J.Sheen, S.D.Lee, and W.Y.Lui. Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma. J. Hepatol. 2009;51:890–897.

    Article  PubMed  Google Scholar 

  6. Tamura,Y., M.Igarashi, T.Suda, T.Wakai, Y.Shirai, T.Umemura, E.Tanaka, S.Kakizaki, H.Takagi, Y.Hiasa, M.Onji, and Y.Aoyagi. Fucosylated fraction of alpha-fetoprotein as a predictor of prognosis in patients with hepatocellular carcinoma after curative treatment. 2009;Dig. Dis. Sci. 55:3576–83.

    Article  Google Scholar 

  7. Malaguarnera,G., M.Giordano, I.Paladina, M.Berretta, A.Cappellani, and M.Malaguarnera. Serum markers of hepatocellular carcinoma. Dig. Dis. Sci. 2010; 55:2744–55.

    Article  PubMed  CAS  Google Scholar 

  8. Weiss,M.J., K.Ray, P.S.Henthorn, B.Lamb, T.Kadesch, and H.Harris. Structure of the human liver/bone/kidney alkaline phosphatase gene. J. Biol. Chem. 1988;263:12002–12010.

    PubMed  CAS  Google Scholar 

  9. Yeh,C.N., M.F.Chen, W.C.Lee, and L.B.Jeng. Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis. J. Surg. Oncol. 2002;81:195–202.

    Article  PubMed  Google Scholar 

  10. Chen,M.F., H.P.Tsai, L.B.Jeng, W.C.Lee, C.N.Yeh, M.C.Yu, and C.M.Hung. Prognostic factors after resection for hepatocellular carcinoma in noncirrhotic livers: univariate and multivariate analysis. World J. Surg. 2003;27:443–447.

    Article  PubMed  Google Scholar 

  11. Leung,T.W., A.M.Tang, B.Zee, W.Y.Lau, P.B.Lai, K.L.Leung, J.T.Lau, S.C.Yu, and P.J.Johnson. Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients. Cancer 2002;94:1760–1769.

    Article  PubMed  Google Scholar 

  12. Qin,L.X. and Z.Y.Tang. The prognostic significance of clinical and pathological features in hepatocellular carcinoma. World J. Gastroenterol. 2002;8:193–199.

    PubMed  Google Scholar 

  13. Eisen,M.B., P.T.Spellman, P.O.Brown, and D.Botstein. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U. S. A 1998; 95:14863–14868.

    Article  PubMed  CAS  Google Scholar 

  14. Pawlik,T.M., K.A.Delman, J.N.Vauthey, D.M.Nagorney, I.O.Ng, I.Ikai, Y.Yamaoka, J.Belghiti, G.Y.Lauwers, R.T.Poon, and E.K.Abdalla. Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl. 2005;11:1086–1092.

    Article  PubMed  Google Scholar 

  15. Vauthey,J.N., G.Y.Lauwers, N.F.Esnaola, K.A.Do, J.Belghiti, N.Mirza, S.A.Curley, L.M.Ellis, J.M.Regimbeau, A.Rashid, K.R.Cleary, and D.M.Nagorney. Simplified staging for hepatocellular carcinoma. J. Clin. Oncol. 2002;20:1527–1536.

    Article  PubMed  Google Scholar 

  16. Lu W, Dong J, Huang Z, Guo D, Liu Y, Shi S. Comparison of four current staging systems for Chinese patients with hepatocellular carcinoma undergoing curative resection: Okuda, CLIP, TNM and CUPI. J Gastroenterol Hepatol. 2008;23:1874–1878

    Article  PubMed  Google Scholar 

  17. Ercolani G, Grazi GL, Ravaioli M, Del Gaudio M, Gardini A, Cescon M, Varotti G, Cetta F, Cavallari A: Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence. Ann Surg 2003;237:536–543.

    PubMed  Google Scholar 

  18. Chen,C.H., F.C.Hu, G.T.Huang, P.H.Lee, Y.M.Tsang, A.L.Cheng, D.S.Chen, J.D.Wang, and J.C.Sheu. Applicability of staging systems for patients with hepatocellular carcinoma is dependent on treatment method—analysis of 2010 Taiwanese patients. 2009; Eur. J. Cancer 45:1630–1639.

    Article  PubMed  Google Scholar 

  19. Tong,M.J., D.Chavalitdhamrong, D.S.Lu, S.S.Raman, A.Gomes, J.P.Duffy, J.C.Hong, and R.W.Busuttil. Survival in Asian Americans after treatments for hepatocellular carcinoma: a seven-year experience at UCLA. J. Clin. Gastroenterol. 2010;44:e63-e70.

    Article  PubMed  Google Scholar 

  20. Sobiesiak,M., K.Sivasubramaniyan, C.Hermann, C.Tan, M.Orgel, S.Treml, F.Cerabona, P.Dezwart, U.Ochs, C.A.Muller, C.E.Gargett, H.Kalbacher, and H.J.Buhring. The mesenchymal stem cell antigen MSCA-1 is identical to tissue non-specific alkaline phosphatase. Stem Cells Dev. 2009; 19:669–77

    Article  Google Scholar 

  21. Russell,W.E., R.J.Coffey, Jr., A.J.Ouellette, and H.L.Moses. Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc Natl Acad Sci U S A. 1988; 85:5126–5130.

  22. Yamamoto,K., T.Awogi, K.Okuyama, and N.Takahashi. Nuclear localization of alkaline phosphatase in cultured human cancer cells. Med. Electron Microsc. 2003;36:47–51.

    Article  PubMed  CAS  Google Scholar 

  23. Changchien,C.S., C.L.Chen, Y.H.Yen, J.H.Wang, T.H.Hu, C.M.Lee, C.C.Wang, Y.F.Cheng, Y.J.Huang, C.Y.Lin, and S.N.Lu. Analysis of 6,381 hepatocellular carcinoma patients in southern Taiwan: prognostic features, treatment outcome, and survival. J. Gastroenterol. 2008;43:159–170.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by the Chang Gung Medical Research Fund (CMRP 361522). The authors acknowledge Ms. Shu-Fang Huang and Ms. Yun-Chieh Lai for data collection and secretarial assistance.

Author information

Authors and Affiliations

  1. Department of Surgery, Chang Gung Memorial Hospital, Linkou No. 5, Fu-Hsing Street, Kuei Shan Hsiang, Taoyuan county, 333, Taiwan

    Ming-Chin Yu, Kun-Ming Chan, Chen-Fang Lee, Firas Zahr Eldeen, Hong-Shiue Chou, Wei-Chen Lee & Miin-Fu Chen

  2. Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan

    Ming-Chin Yu

  3. Genomic Medicine Research Core Laboratory, Chang Gung Memorial Hospital, Taoyuan, Taiwan

    Yun-Shien Lee

Authors
  1. Ming-Chin Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kun-Ming Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chen-Fang Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yun-Shien Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Firas Zahr Eldeen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hong-Shiue Chou
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Wei-Chen Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Miin-Fu Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wei-Chen Lee.

Additional information

There is no commercial interest in the study and the financial support is from Chang Gung Medical Research funding, CMRP 361522.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yu, MC., Chan, KM., Lee, CF. et al. Alkaline Phosphatase: Does it have a Role in Predicting Hepatocellular Carcinoma Recurrence?. J Gastrointest Surg 15, 1440–1449 (2011). https://doi.org/10.1007/s11605-011-1537-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-011-1537-3

Keywords

Search

Navigation